-
Research sites can improve the way they handle regulatory requirements and encourage more investigators to conduct research by making simple changes, an expert says.
-
It might seem too daring to make changes to human subjects oversight programs by easing ethics review procedures. But several research organizations have found that some measured changes can help reduce investigators' regulatory burden without increasing risk to subjects.
-
Increasing numbers of research institutions have opened offices to provide oversight of investigator-initiated clinical trials, but they often lack the basic tools needed for this process.
-
The University of Pittsburgh in Pittsburgh, PA, has developed a thorough, review process that serves as an educational opportunity, as well as a way to prevent clinical research problems.
-
Oncologists and medical directors say that 38% of their patients could benefit from participation in clinical trials, but only about 5% actually enroll in an oncology study per month, according to a recent survey.
-
Each clinical trial administrator and investigator needs to understand the motivations of all parties involved including his or her own before beginning a clinical trial contract negotiation process.
-
-
-
If your patient tells you he's had asthma since he was a teenager, don't assume that he must already know how to self-manage his condition.
-
(Editor's note: This is the second of a two-part series on prevention of hospital-acquired infections in the ED. This month, we give strategies to improve compliance with hand hygiene, tips for cleaning the equipment you use and tell you how to determine if your patient has arrived at the ED with an infection. Last month, we covered avoiding infections when invasive procedures are performed, reducing the risk of infection with peripheral IV insertion, using alternatives to invasive procedures, giving central-line education to ED nurses, and decreasing the use of central lines and urinary catheters.)
